At the most recent edition of the Biomanufacturing World Summit series held November 13th to 15th in San Diego, we spoke with Jon Emery, a Sr. Solutions Engineer with Aizon, about the biopharmaceutical industry's urgent need to break down data silos between manufacturers and their CMO and CDMO partners. As the capacity crunch continues to bottleneck the pipeline of new medicines and therapies, more and more companies are working with contract manufacturers, but tech transfer, QA/QC, regulatory compliance, and a wide range of other information can find itself living with one organization or the other and only being intermittently and incompletely shared. How should the industry work to address this issue?

--

Aizon is an AI software provider that transforms manufacturing operations with the use of advanced analytics, artificial intelligence, and other smart factory technologies focused on optimizing production and quality within highly regulated industries. The Aizon platform seamlessly integrates unlimited sources of structured and unstructured data to deliver actionable insights across all manufacturing sites. Aizon offers an intuitive way to gain meaningful operational intelligence by enabling real-time visibility and predictive insights in a GxP compliant manner with end-to-end data integrity.

www.aizon.ai